HPV DNA Testing for Cervical Cancer Screening
The HPV Test
The HPV test is collected very much like a Pap smear. A cervical brush or other collection device is inserted into the cervix to collect cells for testing. This sample is then sent to the lab for evaluation.
A negative result means that high-risk, cancer-causing types of HPV were not detected. Therefore, your risk of developing high-grade cervical disease before your next routine visit is extremely low.
A positive HPV result may mean an increased risk of developing cervical cancer if the precancerous type is present. In this case, further examination will be needed in order to determine whether your cervix shows pre-cancerous or cancerous changes. If no changes are detected, you will be closely monitored to ensure that any changes are detected as early as possible. If precancerous changes are detected, you should know that several highly effective treatment options are available.
Questions to Ask Your Doctor
To find out if HPV testing is right for you, be sure to ask your doctor the following questions on your next doctor visit:
- Am I a candidate for an HPV test as part of my cervical cancer screening program?
- Do you provide HPV testing as a follow-up to help clarify inconclusive Pap test results?
- If I have an inconclusive Pap test result, can you ask the lab to perform an automatic HPV test from the same Pap sample?
- Will my insurance cover the HPV test?
- Can I talk to you about questions I have about HPV and cervical cancer?
American Cancer Society
National Cancer Institute
Canadian Cancer Society
Society of Obstetricians and Gynaecologists of Canada
American Cancer Society. Cancer Facts & Figures. 2003;19-20.
Cancer facts: human papillomaviruses and cancer. National Cancer Institute website. Available at:
http://cis.nci.nih.gov/fact/3_20.htm . Accessed April 11, 2003.
Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR. 2010;59(No. RR-12):1-110.
Cervical cancer screening (including Pap smears). EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php. Updated March 2010. Accessed April 30, 2010.
Cuzick J. Human papillomavirus testing for primary cervical cancer screening. JAMA . 2000;283:108-109.
Kulasingam SL, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. JAMA . 2002;288:1749-1757.
Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA . 199;281:1605-1610.
New testing strategy for cervical cancer: adding HPV test could improve accuracy. American Cancer Society website. Available at: http://www.cancer.org . Accessed April 11, 2003.
Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA . 2000;283:87-93.
Wright TC, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA . 2002;287:2120-2129.
Wright TC, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81-86.
Last reviewed February 2011 by
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © 2007 EBSCO Publishing All rights reserved.